RICE HALL JAMES & ASSOCIATES, LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 81 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 2.65 and the average weighting 1.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2015$51,000
-26.1%
29,511
-4.3%
0.00%
-25.0%
Q2 2015$69,000
+4.5%
30,842
-9.4%
0.00%0.0%
Q1 2015$66,000
+1.5%
34,052
+39.4%
0.00%0.0%
Q4 2014$65,000
-33.7%
24,422
-25.0%
0.00%
-42.9%
Q3 2014$98,000
-25.8%
32,567
+1.3%
0.01%
-22.2%
Q2 2014$132,000
-3.6%
32,164
+1.5%
0.01%
-10.0%
Q1 2014$137,000
-13.8%
31,701
+4.2%
0.01%
-9.1%
Q4 2013$159,00030,4160.01%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q1 2014
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders